Atlas Trials

An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without CRRT

Clinical trial NCT02962934 · COMPLETED

Trial details

NCT number
NCT02962934
Sponsor
Royal Brisbane and Women's Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Gram-Negative Bacterial Infections
Start date
2016-11-30
Primary completion
2019-06-30
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.